Search Results - "Andersen, N F"

The polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT by Vangsted, A J, Klausen, T W, Ruminski, W, Gimsing, P, Andersen, N F, Gang, A O, Abildgaard, N, Knudsen, L M, Nielsen, J L, Gregersen, H, Vogel, U

“…Proinflammatory cytokines are suspected to play a role in the pathogenesis of multiple myeloma (MM). Therefore, it is possible that inborn genetic variations…”
Get full text

Evolving the narrative for protecting a rapidly changing ocean, post-COVID-19 by Laffoley, D, Baxter, J M, Amon, D J, Claudet, J, Hall-Spencer, J M, Grorud-Colvert, K, Levin, L A, Reid, P C, Rogers, A D, Taylor, M L, Woodall, L C, Andersen, N F

“…The ocean is the linchpin supporting life on Earth, but it is in declining health due to an increasing footprint of human use and climate change. Despite…”
Get full text

Evolving the narrative for protecting a rapidly changing ocean, post‐COVID‐19 by Laffoley, D., Baxter, J.M., Amon, D.J., Claudet, J., Hall‐Spencer, J.M., Grorud‐Colvert, K., Levin, L.A., Reid, P.C., Rogers, A.D., Taylor, M.L., Woodall, L.C., Andersen, N.F.

“…The ocean is the linchpin supporting life on Earth, but it is in declining health due to an increasing footprint of human use and climate change. Despite…”
Get full text

Salvage bortezomib–dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial by Gimsing, P, Hjertner, Ø, Abildgaard, N, Andersen, N F, Dahl, T G, Gregersen, H, Klausen, T W, Mellqvist, U-H, Linder, O, Lindås, R, Tøffner Clausen, N, Lenhoff, S

“…Until recently, only retrospective studies had been published on salvage high-dose melphalan (HDM) with autologous stem cell ‘transplantation’ (ASCT). In a…”
Get full text

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial by Mellqvist, Ulf-Henrik, Gimsing, Peter, Hjertner, Oyvind, Lenhoff, Stig, Laane, Edward, Remes, Kari, Steingrimsdottir, Hlif, Abildgaard, Niels, Ahlberg, Lucia, Blimark, Cecilie, Dahl, Inger Marie, Forsberg, Karin, Gedde-Dahl, Tobias, Gregersen, Henrik, Gruber, Astrid, Guldbrandsen, Nina, Haukås, Einar, Carlson, Kristina, Kvam, Ann Kristin, Nahi, Hareth, Lindås, Roald, Andersen, Niels Frost, Turesson, Ingemar, Waage, Anders, Westin, Jan

“…The Nordic Myeloma Study Group conducted an open randomized trial to compare bortezomib as consolidation therapy given after high-dose therapy and autologous…”
Get full text

Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group by Gregersen, Henrik, Peceliunas, Valdas, Remes, Kari, Schjesvold, Fredrik, Abildgaard, Niels, Nahi, Hareth, Andersen, Niels Frost, Vangsted, Annette Juul, Klausen, Tobias Wirenfeldt, Helleberg, Carsten, Carlson, Kristina, Frølund, Ulf Christian, Axelsson, Per, Stromberg, Olga, Blimark, Cecilie Hveding, Crafoord, Jacob, Tsykunova, Galina, Eshoj, Henrik Rode, Waage, Anders, Hansson, Markus, Gulbrandsen, Nina

“…Objective We investigated the efficacy and safety of carfilzomib‐containing induction before salvage high‐dose melphalan with autologous stem‐cell…”
Get full text

Renal function in 153 manic-depressive patients treated with lithium for more than five years by Løkkegaard, H, Andersen, N F, Henriksen, E, Bartels, P D, Brahm, M, Baastrup, P C, Jørgensen, H E, Larsen, M, Munck, O, Rasmussen, K

“…Renal function was examined in 153 manic-depressive patients treated with lithium for more than 5 years, mean 10 years. No significant change was detectable in…”
Get more information

A Randomized Phase 2 Trial Comparing Carfilzomib-Dexamethasone Vs Observation As Maintenance after Induction with Carfilzomib-Cyclophosphamide-Dexamethasone in Salvage ASCT in Multiple Myeloma: A Trial By the Nordic Myeloma Study Group by Gregersen, Henrik, Peceliunas, Valdas, Remes, Kari, Schjesvold, Fredrik H., Abildgaard, Niels, Nahi, Hareth, Andersen, Niels Frost, Vangsted, Annette Juul, Klausen, Tobias Wirenfeldt, Helleberg, Carsten, Carlson, Kristina, Frølund, Ulf Christian, Axelsson, Per, Stromberg, Olga, Blimark, Cecilie Hveding, Linder, Olle, Tsykunova, Galina, Waage, Anders, Hansson, Markus, Gulbrandsen, Nina

“…Background: Salvage autologous stem cell transplantation (ASCT) is used in selected patients with relapsed multiple myeloma after up-front ASCT. However, there…”
Get full text

The polymorphism IL-1[beta] T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT by Vangsted, A J, Klausen, T W, Ruminski, W, Gimsing, P, Andersen, N F, Gang, A O, Abildgaard, N, Knudsen, L M, Nielsen, J L, Gregersen, H, Vogel, U

“…Proinflammatory cytokines are suspected to play a role in the pathogenesis of multiple myeloma (MM). Therefore, it is possible that inborn genetic variations…”
Get full text

A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma by Gregersen, Henrik, Abildgaard, Niels, Hieu Do, Trung, Kristensen, Ida Bruun, Frølund, Ulf Christian, Andersen, Niels Frost, Nielsen, Lene Kongsgaard, Andersen, Christen Lykkegaard, Klausen, Tobias Wirenfeldt, Vangsted, Annette Juul

“…▪ Background: Uncontrolled studies and a case-matched study indicate that clarithromycin might exert synergistic effects in combination with thalidomide or…”
Get full text

A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support by Vangsted, Annette J, Klausen, Tobias W, Gimsing, Peter, Andersen, Niels F, Abildgaard, Niels, Gregersen, Henrik, Vogel, Ulla

“…1 Dept. of Oncology and Haematology, Roskilde Hospital, Copenhagen Univesity, Roskilde 2 Dept. of Haematology, University Hospital of Copenhagen at Herlev 3…”
Get full text

The Danish National Multiple Myeloma Registry by Gimsing, Peter, Holmström, Morten O, Klausen, Tobias Wirenfelt, Andersen, Niels Frost, Gregersen, Henrik, Pedersen, Robert Schou, Plesner, Torben, Pedersen, Per Trøllund, Frederiksen, Mikael, Frølund, Ulf, Helleberg, Carsten, Vangsted, Annette, de Nully Brown, Peter, Abildgaard, Niels

“…The Danish National Multiple Myeloma Registry (DMMR) is a population-based clinical quality database established in January 2005. The primary aim of the…”
Get full text

Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation: data from a Nordic phase II trial by Eshoj, Henrik Rode, Nielsen, Lene Kongsgaard, Schjesvold, Fredrik, Abildgaard, Niels, Nahi, Hareth, Andersen, Niels Frost, Vangsted, Annette Juul, Helleberg, Carsten, Frølund, Ulf Christian, Axelsson, Per, Stromberg, Olga, Blimark, Cecilie, Carlson, Kristina, Waage, Anders, Remes, Kari, Peceliunas, Valdas, Guldbrandsen, Nina, Hansson, Markus, Gregersen, Henrik

Get full text

Syndecan‐1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival by Andersen, Niels Frost, Standal, Therese, Nielsen, Johan Lanng, Heickendorff, Lene, Borset, Magne, Sørensen, Flemming Brandt, Abildgaard, Niels

“…Summary Angiogenesis is a complex process involved in the proliferation and metastasis of malignant tumours, and partly triggered by the secretion of various…”
Get full text

Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study by Hjorth, Martin, Hjertner, Øyvind, Knudsen, Lene Meldgaard, Gulbrandsen, Nina, Holmberg, Erik, Pedersen, Per Trøllund, Andersen, Niels Frost, Andréasson, Björn, Billström, Rolf, Carlson, Kristina, Carlsson, Margaretha S., Flogegård, Max, Forsberg, Karin, Gimsing, Peter, Karlsson, Torbjörn, Linder, Olle, Nahi, Hareth, Othzén, Annika, Swedin, Agneta

“…Objectives:  Thalidomide and bortezomib have been frequently used for second‐line therapy in patients with myeloma relapsing after or refractory to initial…”
Get full text

Intranasal calcitonin and prevention of postmenopausal bone loss by Thamsborg, G, Storm, T, Sykulski, R, Brinch, E, Andersen, N F, Holmegard, S N, Soerensen, O H

Get more information

Piperacillin-resistant Escherichia coli bacteraemia: Relation to empiric therapy and clinical outcome by Andersen, Niels Frost, Møller, Jens K., Peterslund, Niels Anker

“…Escherichia coli is a leading cause of bacteraemia. The aim of this study was to evaluate all E. coli positive blood cultures collected during a 4-y period in…”
Get full text

Low seroprevalence of Bartonella species in danish elite orienteers by Schiellerup, Peter, Dyhr, Thomas, Marc Rolain, Jean, Christensen, Marianne, Damsgaard, Rasmus, Ethelberg, Steen, Fisker, Niels, Frost Andersen, Niels, Raoult, Didier, Krogfelt, Karen A.

“…In the 1990s, studies were conducted to investigate 16 episodes of sudden unexpected cardiac death (SUCD) among Swedish elite orienteers during the period from…”
Get full text

The polymorphism IL-1beta T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT by Vangsted, A J, Klausen, T W, Ruminski, W, Gimsing, P, Andersen, N F, Gang, A O, Abildgaard, N, Knudsen, L M, Nielsen, J L, Gregersen, H, Vogel, U

“…Proinflammatory cytokines are suspected to play a role in the pathogenesis of multiple myeloma (MM). Therefore, it is possible that inborn genetic variations…”
Get full text

Data quality of the monoclonal gammopathy of undetermined significance diagnosis in a hospital registry by Gregersen, Henrik, Larsen, Caroline Brenner, Haglund, Anne, Mortensen, Rikke, Andersen, Niels Frost, Nørgaard, Mette

“…To estimate the positive predictive value (PPV) and completeness of the monoclonal gammopathy of undetermined significance (MGUS) diagnosis coding in a…”
Get full text